Effect of isatuximab plus pomalidomide/dexamethasone on renal impairment in relapsed/refractory multiple myeloma: ICARIA-MM study subgroup analysis.
Saved in:
| Title: | Effect of isatuximab plus pomalidomide/dexamethasone on renal impairment in relapsed/refractory multiple myeloma: ICARIA-MM study subgroup analysis. |
|---|---|
| Authors: | Dimopoulos, Meletios A., Leleu, Xavier, Moreau, Philippe, Attal, Michel, Richardson, Paul G., Liberati, Anna Marina, Harrison, Simon J., Prince, H. Miles, Ocio, Enrique M., Assadourian, Sylvie, Campana, Frank, Malinge, Laure, van de Velde, Helgi, Yong, Kwee |
| Source: | Clinical lymphoma, myeloma & leukemia Oct2019 Supplement; Vol. 19. |
| Journal Info: | Publisher: Elsevier B.V. ISSN: 2152-2650 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2152-2669 |
|---|---|
| DOI: | 10.1016/j.clml.2019.09.420 |
